BEDEL FINANCIAL CONSULTING INC
CIK
850553
Location
INDIANAPOLIS, IN
Portfolio Value
Small
$187,016,361
Diversification
Highly concentrated
Filing Date
Sep 30, 2023
Global Rank
#2,658
/ 6,879
Top Industry
Drug Manufacturers - General
64.3%
3Y Alpha vs SPY
+0.7%
Period ended 2 years ago
Filed Nov 1, 2023 · 2y
Clone Performance
Nov 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+76.4%
SPY
+73.8%
Annualised alpha
+0.7%
Max drawdown
−19.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
131 positions · as of Sep 30, 2023Top Position
60.1%
of portfolio value
Top 5
73.5%
of portfolio value
Top 10
78.5%
of portfolio value
HHI
3,678
Highly concentrated
Sector Breakdown
As of Sep 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 64.3% | $187,016,361 |
| Technology | 12.3% | $35,839,112 |
| Financial Services | 5.8% | $16,795,891 |
| Consumer Defensive | 3.3% | $9,580,570 |
| Consumer Cyclical | 3.2% | $9,272,780 |
| Industrials | 3.0% | $8,600,311 |
| Unclassified | 2.6% | $7,535,933 |
| Communication Services | 2.0% | $5,739,893 |
| Energy | 1.8% | $5,196,423 |
| Utilities | 0.9% | $2,592,512 |
| Real Estate | 0.5% | $1,347,151 |
| Basic Materials | 0.4% | $1,249,399 |
20 positions ·
$187,016,361 total
· Healthcare only
· as of Sep 30, 2023
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
First | 10,000 | $30,000 | 0.02% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
First | 15,000 | $50,250 | 0.03% | |
| XRAY |
DENTSPLY SIRONA Inc.
Healthcare
|
First | 6,254 | $213,636 | 0.11% | |
| CI |
Cigna Group
Healthcare
|
First | 754 | $215,696 | 0.12% | |
| GSK |
GSK plc
Healthcare
|
First | 6,886 | $249,617 | 0.13% | |
| RMD |
Resmed Inc
Healthcare
|
First | 2,100 | $310,527 | 0.17% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
First | 5,862 | $340,230 | 0.18% | |
| AMGN |
Amgen Inc
Healthcare
|
First | 1,447 | $388,895 | 0.21% | |
| NVS |
Novartis AG
Healthcare
|
First | 4,445 | $452,767 | 0.24% | |
| SYK |
Stryker Corp
Healthcare
|
First | 1,733 | $473,576 | 0.25% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
First | 1,000 | $504,190 | 0.27% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
First | 1,227 | $534,260 | 0.29% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
First | 6,159 | $634,069 | 0.34% | |
| BSX |
Boston Scientific Corp
Healthcare
|
First | 13,053 | $689,198 | 0.37% | |
| DHR |
Danaher Corp /De/
Healthcare
|
First | 3,938 | $866,150 | 0.46% | |
| PFE |
Pfizer Inc
Healthcare
|
First | 29,475 | $977,685 | 0.52% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
First | 3,481 | $1,017,461 | 0.54% | |
| ABBV |
AbbVie Inc.
Healthcare
|
First | 12,629 | $1,882,478 | 1.01% | |
| JNJ |
Johnson & Johnson
Healthcare
|
First | 14,946 | $2,327,839 | 1.24% | |
| LLY |
ELI LILLY & Co
Healthcare
|
First | 325,541 | $174,857,837 | 93.50% |